[一种来自Euphorbia thymifolia的具有抗炎活性的新型亚特罗二甲]
Yang-Yang Liu1, Chang-He Liang2, Jiang-Ying Cao2
1College of Pharmacy, Shandong University of Traditional Chinese Medicine Ji'nan 250355, China Shandong Co-Innovation Center of Classic Traditional Chinese Medicine Formula (Shandong University of Traditional Chinese Medicine) Ji'nan 250355, China.
概括
研究人员从Euphorbia thymifolia中分离出了10种化合物,其中包括一种新的贾特罗类型的迪特尔化物. 这种新化合物在细胞测试中显示出氧化 (NO) 抑制活性.
科学领域:
- 植物化学 植物化学
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 优草 (Euphorbia thymifolia) 是一种具有传统使用历史的药用植物.
- 迪特尔类和类是众所周知的各种生物活动的自然产品类.
研究的目的:
- 从Euphorbia thymifolia的上空部分中分离和描述化学成分.
- 评估分离化合物的潜在生物活性.
主要方法:
- 使用色谱技术 (MCI,ODS,HPLC) 进行提取和分离.
- 通过光谱方法 (UV,IR,NMR,MS) 阐明结构.
- 在体外测试,检测LPS诱导的BV-2细胞中氧化 (NO) 抑制活性.
主要成果:
- 他们分离了10种化合物:五种雅特罗类型的迪特尔类 (1-5),三种阿比类型的迪特尔类 (6-8) 和两种类 (9-10).
- 化合物1 (euphthymifolone A) 是一种新型化合物.
- 化合物9 (anabellamide) 和10 (aurantiamide) 是首次从Euphorbia属中分离出来的.
- 化合物1表现出氧化 (NO) 抑制活性,其IC50为65.4±1.36 μmol·L−1.1.
结论:
- 对Euphorbia thymifolia的化学研究产生了一种新型的二甲和几个已知的化合物.
- 隔离的新化合物通过NO抑制显示出潜在的抗炎性质.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Antiasthma Drugs: Methylxanthines
1.6K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
Antiasthma Drugs: Muscarinic Receptor Antagonists
1.7K
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
1.7K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K


